找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Antibodies; Volume 1: Production G. Subramanian Book 2004 Springer Science+Business Media New York 2004 HIV.cancer.cancer therapy.developme

[復(fù)制鏈接]
樓主: Harrison
31#
發(fā)表于 2025-3-26 21:22:08 | 只看該作者
32#
發(fā)表于 2025-3-27 05:10:28 | 只看該作者
Large-Scale Production of Therapeutic Antibodies: Considerations for Optimizing Product Capture andlin, most of the initial wave of biotechnology products launched in the 1980s and 1990s were peptide hormones and enzymes licensed for indications with relatively small patient populations and for short-term rather than chronic use. Consequently, the market requirement for these products was frequently in the low kilogram range.
33#
發(fā)表于 2025-3-27 07:39:36 | 只看該作者
Contract Manufacturing of Biopharmaceutical Grade Antibodies,harmaceuticals. With a significant higher number in clinical trials and the search for new recombinant proteins as a result of the human genome sequencing program it is expected that many more human antibodies will enter the market in years to come (Gura, 2002, Walsh, 2000).
34#
發(fā)表于 2025-3-27 13:23:07 | 只看該作者
35#
發(fā)表于 2025-3-27 17:01:52 | 只看該作者
36#
發(fā)表于 2025-3-27 19:47:02 | 只看該作者
Einführung in die lineare Algebraain clinical indications. Consequently a variety of antibody fragments and conjugates have been developed that address specific applications and facilitate their production using low cost, microbial expression systems. This chapter will review key considerations in the formatting of antibody fragmen
37#
發(fā)表于 2025-3-27 23:49:28 | 只看該作者
38#
發(fā)表于 2025-3-28 02:44:30 | 只看該作者
39#
發(fā)表于 2025-3-28 07:21:07 | 只看該作者
Antibody Fragments,ain clinical indications. Consequently a variety of antibody fragments and conjugates have been developed that address specific applications and facilitate their production using low cost, microbial expression systems. This chapter will review key considerations in the formatting of antibody fragmen
40#
發(fā)表于 2025-3-28 11:09:48 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 20:01
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
日土县| 行唐县| 内江市| 宁蒗| 格尔木市| 石首市| 嘉荫县| 都兰县| 墨玉县| 辽源市| 吴堡县| 竹北市| 崇州市| 城市| 山阳县| 绵竹市| 蒙自县| 盐山县| 洛阳市| 翁源县| 西昌市| 克什克腾旗| 阿拉善右旗| 阜宁县| 余姚市| 汉阴县| 黔南| 周宁县| 宜昌市| 进贤县| 江陵县| 彰化县| 博罗县| 习水县| 和田市| 隆安县| 临泽县| 湟源县| 乐安县| 徐闻县| 榆社县|